You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 5, May 1957 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Radioactive Phosphorus Uptake Test for Malignant Melanoma of the Eye

A Study of Forty Consecutive Cases of Suspected Intraocular Malignant Melanomas

ANTHONY DONN, M.D.; JOHN W. McTIGUE, M.D.

AMA Arch Ophthalmol. 1957;57(5):668-671.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Since the first report by Thomas, Krohmer, and Storaasli, in 1952,1 many excellent studies have confirmed the fact that the measureable uptake of radioactive phosphorus is greater over malignant melanomas of the eye than over normal ocular tissue, intraocular hemorrhage, or serous retinal detachments.2-14 A wealth of case reports in these papers documents the fact that this difference in uptake may be used clinically to distinguish a malignant melanoma from a more benign condition in the eye. As the experience with this technique has increased, however, it has also become apparent that there are three important limitations to the clinical effectiveness of this test: (1) Lesions at the posterior pole may not be accessible to the probe counter; (2) inflammatory lesions may give false-positive readings for malignant melanomas; (3) inaccuracies inherent in the counting procedure may give false results. For these reasons, a good deal of skepticism . . . [Full Text PDF of this Article]


Author Affiliations

New York

From the Institute of Ophthalmology of the Presbyterian Hospital.


Footnotes

Received for publication Jan. 16, 1957.

This study was supported by Grant 156 from the National Council to Combat Blindness.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1957 American Medical Association. All Rights Reserved.